[HTML][HTML] Virtual reality (VR) in assessment and treatment of addictive disorders: a systematic review
…, JV Blanc, CS Peretti, S Mouchabac, F Ferreri - Frontiers in …, 2020 - frontiersin.org
Background: Substance Use Disorder (SUD) and behavioral addictions are common and
require a multidisciplinary approach. New technologies like Virtual Reality could have the …
require a multidisciplinary approach. New technologies like Virtual Reality could have the …
Current research on cognitive aspects of anxiety disorders
F Ferreri, LK Lapp, CS Peretti - Current opinion in psychiatry, 2011 - journals.lww.com
Advances have clearly been made in the elucidation of the cognitive functioning associated
with anxiety disorders. It remains unclear if particular cognitive profiles can help to …
with anxiety disorders. It remains unclear if particular cognitive profiles can help to …
[HTML][HTML] e-Addictology: an overview of new technologies for assessing and intervening in addictive behaviors
F Ferreri, A Bourla, S Mouchabac, L Karila - Frontiers in psychiatry, 2018 - frontiersin.org
Background New technologies can profoundly change the way we understand psychiatric
pathologies and addictive disorders. New concepts are emerging with the development of …
pathologies and addictive disorders. New concepts are emerging with the development of …
[HTML][HTML] Inter-relationships between isotretinoin treatment and psychiatric disorders: depression, bipolar disorder, anxiety, psychosis and suicide risks
M Ludot, S Mouchabac, F Ferreri - World journal of psychiatry, 2015 - ncbi.nlm.nih.gov
Isotretinoin (Accutane) is a treatment for severe acne that is resistant to other forms of
treatment, including antibiotics and topical treatments. The prescription of this drug has been …
treatment, including antibiotics and topical treatments. The prescription of this drug has been …
Management of post traumatic stress disorder after childbirth: a review
…, C Agbokou, CS Peretti, F Ferreri - Journal of Psychosomatic …, 2010 - Taylor & Francis
Prevalence and risk factors for the development of post traumatic stress disorder (PTSD) after
childbirth is well described in the literature. However, its management and treatment has …
childbirth is well described in the literature. However, its management and treatment has …
Recognition and management of neuropsychiatric complications in Parkinson's disease
F Ferreri, C Agbokou, S Gauthier - Cmaj, 2006 - Can Med Assoc
Parkinson's disease is primarily considered a motor disease characterized by rest tremor,
rigidity, bradykinesia and postural disturbances. However, neuropsychiatric complications, …
rigidity, bradykinesia and postural disturbances. However, neuropsychiatric complications, …
PTSD in the elderly: the interaction between trauma and aging
LK Lapp, C Agbokou, F Ferreri - International Psychogeriatrics, 2011 - cambridge.org
Background: Because an increasingly large cohort of individuals is approaching their
elderly years, there is concern about how the healthcare system will cope with the greater …
elderly years, there is concern about how the healthcare system will cope with the greater …
Social cognition in post‐traumatic stress disorder: A systematic review
…, A Bourla, P Nuss, F Ferreri - British Journal of …, 2020 - Wiley Online Library
Objectives Post‐traumatic stress disorder (PTSD) is a common psychiatric condition. Patients
with PTSD have marked symptoms that significantly impair their social and emotional …
with PTSD have marked symptoms that significantly impair their social and emotional …
e-PTSD: an overview on how new technologies can improve prediction and assessment of Posttraumatic Stress Disorder (PTSD)
…, S Mouchabac, W El Hage, F Ferreri - European Journal of …, 2018 - Taylor & Francis
Background: New technologies may profoundly change our way of understanding psychiatric
disorders including posttraumatic stress disorder (PTSD). Imaging and biomarkers, along …
disorders including posttraumatic stress disorder (PTSD). Imaging and biomarkers, along …
[HTML][HTML] Treating major depressive episodes with antidepressants can induce or worsen metabolic syndrome: results of the METADAP cohort
…, AC Petit, F Gressier, S Brailly-Tabard, F Ferreri… - World …, 2015 - ncbi.nlm.nih.gov
Recent data (1-4) show a high comorbidity between major depressive disorder and
metabolic syndrome (MetS)(5), a cluster of risk factors for cardiovascular diseases and type 2 …
metabolic syndrome (MetS)(5), a cluster of risk factors for cardiovascular diseases and type 2 …